SMTL ID : 5alb.1

Ticagrelor antidote candidate MEDI2452 in complex with ticagrelor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.16 Å

Oligo State

hetero-1-1-mer

Ligands

1 x TIQ: Ticagrelor(Non-covalent)

TIQ.1: 24 residues within 4Å: Chain A: S.33, H.35, W.47, G.50, I.52, T.57, L.58, S.59, Y.103, W.106, P.112, D.114, A.115, L.116 Chain B: S.35, Y.37, G.90, T.91, W.92, Y.94, A.97, G.99, L.100, F.101 13 PLIP interactions: 6 interactions with chain A, 7 interactions with chain B Hydrophobic interactions: A:W.106, A:L.116, B:W.92, B:W.92, B:W.92 Hydrogen bonds: A:S.33, A:T.57, A:Y.103, A:D.114, B:W.92 pi-Stacking: B:W.92, B:W.92, B:W.92

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Buchanan, A. et al., Structural and Functional Characterisation of a Specific Antidote for Ticagrelor. Blood (2015)

Release Date

2015-04-01

Peptides

MEDI2452 HEAVY CHAIN: A
MEDI2452 LIGHT CHAIN: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

MEDI2452 HEAVY CHAIN

MEDI2452 LIGHT CHAIN